For example, Hu et al. (2022) reported that CBX2 downregulates tumour suppressor genes (PPARG, OLR1 and FABP5) through epigenetic modification of the promoter region to promote the growth and metastasis of lung adenocarcinoma. This evidence concerns the gene CBX2 and neoplasm.